BRIEF-Caribou Biosciences To Evaluate Strategic Alternatives

Reuters2026/10/06 20:20

Caribou Biosciences, Inc. CRBU.O: CARIBOU BIOSCIENCES TO EVALUATE STRATEGIC ALTERNATIVES CARIBOU BIOSCIENCES - TO DISCONTINUE VISPA-CEL AND CB-011 CAR-T CELL THERAPY PROGRAMS CARIBOU BIOSCIENCES - TO IMPLEMENT WORKFORCE AND COST REDUCTIONS CARIBOU BIOSCIENCES - PLANS SUBSTANTIAL WORKFORCE REDUCTION EXPECTED TO BE MOSTLY COMPLETE IN Q4 2026 CARIBOU BIOSCIENCES - REPORTS CASH AND SECURITIES OF $113.80 MILLION AS OF JUNE 30, 2026 Source text: ID:nGNXF64mr Further company coverage: CRBU.O

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

US storage stocks fell across the board in pre-market trading, with SK Hynix down over 2%

格隆汇•2026/11/09 09:24

Jensen Huang's influence surpasses that of Nvidia— and that's exactly the problem

Jensen Huang has been the key driving force behind the massive expansion of AI infrastructure, with his personal credibility and authoritative decision-making deeply embedded in the narrative of the global tech market’s rise over the past three years. Now, as scandals emerge, Nvidia’s trading team is expected to become more conservative and slow down external financing commitments, which undoubtedly worsens the situation for neoclouds already facing tight funding.

华尔街见闻•2026/11/09 09:21

BUZZ - Nvidia stock falls as board launches investigation into CEO over espionage allegations

路透社•2026/11/09 09:21

Deutsche Bank made significant Q3 purchases of midstream AI application stocks: the three major cloud giants saw increased holdings, with Palantir (PLTR.US) and Salesforce (CRM.US) also favored.

Deutsche Bank has submitted its third quarter 13F holdings report for the period ending September 30, 2026.

智通财经•2026/11/09 09:11